BNP Paribas Financial Markets’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
134,594
-8,011
-6% -$79.3K ﹤0.01% 3021
2026
Q1
$1.31M Buy
142,605
+21,421
+18% +$178K ﹤0.01% 2949
2025
Q4
$900K Buy
121,184
+23,093
+24% +$158K ﹤0.01% 3183
2025
Q3
$666K Buy
98,091
+49,763
+103% +$337K ﹤0.01% 3398
2025
Q2
$334K Buy
48,328
+19,047
+65% +$129K ﹤0.01% 3561
2025
Q1
$213K Sell
29,281
-17,837
-38% -$140K ﹤0.01% 3655
2024
Q4
$378K Buy
+47,118
New +$409K ﹤0.01% 3466

Other funds holding VMD

BNP Paribas Financial Markets's VMD Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Viemed Healthcare (VMD) stake by 5.6% in Q2 2026, selling an estimated $79.3K and leaving 134,594 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3021.

BNP Paribas Financial Markets first reported a position in VMD in Q4 2024 and has held it in 7 quarters since. 164 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • BNP Paribas Financial Markets held 134,594 shares of Viemed Healthcare worth $1.53M as of Q2 2026.
  • BNP Paribas Financial Markets sold 8,011 Viemed Healthcare shares in Q2 2026, an estimated $79.3K.
  • Viemed Healthcare made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3021 holding.
  • BNP Paribas Financial Markets first reported a position in Viemed Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 164 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.